Buhisan, Hanifa K.

HRN: 28-33-40  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/23/2026
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
03/23/2026
03/30/2026
ORAL
3000 U
QID
THRUSH
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Eye, Ear, Nose, Throat, & Mouth    Compliance to guidelines: